Home > Compound List > Product Information
Dehydroleucodine_Molecular_structure_CAS_36150-07-9)
Click picture or here to close

Dehydroleucodine

Catalog No. D4196 Name Sigma Aldrich
CAS Number 36150-07-9 Website http://www.sigmaaldrich.com
M. F. C15H16O3 Telephone 1-800-521-8956
M. W. 244.28574 Fax
Purity ≥98% (HPLC) Email
Storage desiccated Chembase ID: 154820

SYNONYMS

IUPAC name
(3aS,9aS,9bS)-6,9-dimethyl-3-methylidene-2H,3H,3aH,4H,5H,7H,9aH,9bH-azuleno[4,5-b]furan-2,7-dione
IUPAC Traditional name
(3aS,9aS,9bS)-6,9-dimethyl-3-methylidene-3aH,4H,5H,9aH,9bH-azuleno[4,5-b]furan-2,7-dione
Synonyms
dehydro-
Lidbeckialactone
Dehydroleucodin
11,13-Dehydroleucodin
Leucodin
Mesatlantin E
NSC 180034
[3aS-(3aalpha,9aalpha,9bbeta)]-3,3a,4,5,9a,9b-hexahydro-6,9-dimethyl-3-methylene-azuleno[4,5-b]furan-2,7-dione

DATABASE IDS

MDL Number MFCD06794926
CAS Number 36150-07-9

PROPERTIES

Empirical Formula (Hill Notation) C15H16O3
Purity ≥98% (HPLC)
Apperance white to off-white powder
Solubility DMSO: ≥30 mg/mL
MSDS Link Download
Storage Condition desiccated
Storage Condition protect from light
Storage Condition under inert gas
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Dehydroleucodine is a sesquiterpene lactone isolated from Artemisia douglasiana Besser; mast cell stabilizers. An extract from the plant is widely used in Cuyo region (Argentina) as folk medicine for the treatment of gastric ailments. The compound prevents gastric and duodenal damages in response to necrosis-inducing agents. Stabilization of mast cells may be a key mechanism to protect the gastrointestinal tract from injury and ulceration. Recently, it was established that dehydroleucodine and xanthatin inhibit mast cell degranulation induced by compound 48/80.
Description (简体中文)
Biochem/physiol Actions
Dehydroleucodine is a sesquiterpene lactone isolated from Artemisia douglasiana Besser; mast cell stabilizers. An extract from the plant is widely used in Cuyo region (Argentina) as folk medicine for the treatment of gastric ailments. The compound prevents gastric and duodenal damages in response to necrosis-inducing agents. Stabilization of mast cells may be a key mechanism to protect the gastrointestinal tract from injury and ulceration. Recently, it was established that dehydroleucodine and xanthatin inhibit mast cell degranulation induced by compound 48/80.

REFERENCES